{"id":11126,"date":"2023-03-06T00:00:00","date_gmt":"2023-03-06T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/1970\/01\/01\/natco-pharma-canada-inc-annonce-le-lancement-de-prnat-pomalidomide-en-capsules-la-premiere-alternative-generique-a-pomalyst-au-canada\/"},"modified":"2025-08-19T08:28:12","modified_gmt":"2025-08-19T13:28:12","slug":"natco-pharma-canada-inc-annonce-le-lancement-de-prnat-pomalidomide-en-capsules-la-premiere-alternative-generique-a-pomalyst-au-canada","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2023\/03\/06\/natco-pharma-canada-inc-annonce-le-lancement-de-prnat-pomalidomide-en-capsules-la-premiere-alternative-generique-a-pomalyst-au-canada\/","title":{"rendered":"NATCO PHARMA (CANADA) INC. ANNONCE LE LANCEMENT DE PRNAT-POMALIDOMIDE EN CAPSULES, LA PREMI\u00c8RE ALTERNATIVE G\u00c9N\u00c9RIQUE \u00c0 POMALYST\u00ae AU CANADA"},"content":{"rendered":"<p>Natco Pharma (Canada) inc., une filiale de Natco Pharma limit\u00e9e, a annonc\u00e9 aujourd&rsquo;hui le lancement de&nbsp;<sup>Pr<\/sup>NAT-POMALIDOMIDE&nbsp;en&nbsp;capsules, la premi\u00e8re alternative g\u00e9n\u00e9rique \u00e0 POMALYST<sup>&nbsp;\u00ae<\/sup>&nbsp;\u00e0 \u00eatre approuv\u00e9e par Sant\u00e9&nbsp;Canada.<\/p>\n<p><sup>Pr<\/sup>NAT-POMALIDOMIDE&nbsp;est utilis\u00e9 en association avec la dexam\u00e9thasone et le bort\u00e9zomib pour le traitement des patients adultes atteints de my\u00e9lome multiple ayant d\u00e9j\u00e0 re\u00e7u au moins un traitement ant\u00e9rieur comprenant de la l\u00e9nalidomide. Il est \u00e9galement utilis\u00e9 en association avec la dexam\u00e9thasone pour les patients atteints de my\u00e9lome multiple chez qui le bort\u00e9zomib et la l\u00e9nalidomide ont \u00e9chou\u00e9, qui ont d\u00e9j\u00e0 re\u00e7u au moins deux formes de traitement et dont la maladie a progress\u00e9 lors du plus r\u00e9cent traitement.<\/p>\n<p><a class=\"ButtonSimple\" href=\"https:\/\/www.newswire.ca\/fr\/news-releases\/natco-pharma-canada-inc-annonce-le-lancement-de-prnat-pomalidomide-en-capsules-la-premiere-alternative-generique-a-pomalyst-r-au-canada-898098927.html\" target=\"_blank\" rel=\"noopener\">Lire la suite ici<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Natco Pharma (Canada) inc., une filiale de Natco Pharma limit\u00e9e, a annonc\u00e9 aujourd&rsquo;hui le lancement de&nbsp;PrNAT-POMALIDOMIDE&nbsp;en&nbsp;capsules, la premi\u00e8re alternative g\u00e9n\u00e9rique \u00e0 POMALYST&nbsp;\u00ae&nbsp;\u00e0 \u00eatre approuv\u00e9e par Sant\u00e9&nbsp;Canada. PrNAT-POMALIDOMIDE&nbsp;est utilis\u00e9 en association avec la dexam\u00e9thasone et le bort\u00e9zomib pour le traitement des patients adultes atteints de my\u00e9lome multiple ayant d\u00e9j\u00e0 re\u00e7u au moins un traitement ant\u00e9rieur comprenant [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53,50,58,52],"tags":[],"class_list":["post-11126","post","type-post","status-publish","format-standard","hentry","category-actualites-et-evenement","category-news-events","category-nouvelles-de-myelome-canada","category-whats-new-at-myeloma-canada"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=11126"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11126\/revisions"}],"predecessor-version":[{"id":31270,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11126\/revisions\/31270"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=11126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=11126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=11126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}